Top compounds associated with response to CCDC155


Feature Type Standardized
Nominal ANOVA
mRNA VX-680 GDSC1000 pan-cancer AAC -0.059 0.3
mRNA dacarbazine CTRPv2 pan-cancer AAC -0.034 0.3
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC 0.08 0.3
mRNA paclitaxel gCSI pan-cancer AAC 0.062 0.3
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.038 0.3
mRNA FQI-1 CTRPv2 pan-cancer AAC -0.05 0.3
mRNA I-BET-762 GDSC1000 pan-cancer AAC 0.029 0.3
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.036 0.3
mRNA BRD-A02303741:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.04 0.3
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC -0.034 0.3
Download CSV